Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong S-M, Zhao M, Rudek MA, Khan SR et al..  2012.  A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.. Mol Cancer Ther. 11(1):165-73.

Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, Darnell RB, Leslie CS, Rudensky AY.  2012.  Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting.. Mol Cell. 48(5):760-70.

Phillips S, Stanley L, Nicoletto H, Burkman M, Laskowitz DT, Cairns CB.  2012.  Use of emergency department transcranial Doppler assessment of reperfusion after intravenous tPA for ischemic stroke.. J Emerg Med. 42(1):40-3.

Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA.  2012.  Using the BLT humanized mouse as a stem cell based gene therapy tumor model.. J Vis Exp. (70):e4181.

Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A et al..  2011.  Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.. Proc Natl Acad Sci U S A. 108(51):E1408-16.

Wei H-J, Wu ATH, Hsu C-H, Lin Y-P, Cheng W-F, Su C-H, Chiu W-T, Whang-Peng J, Douglas FL, Deng W-P.  2011.  The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine.. Mol Ther. 19(12):2249-57.

Glickman SW, Phillips S, Anstrom KJ, Laskowitz DT, Cairns CB.  2011.  Discriminative capacity of biomarkers for acute stroke in the emergency department.. J Emerg Med. 41(3):333-9.

Butcher MJ, Herre M, Ley K, Galkina E.  2011.  Flow cytometry analysis of immune cells within murine aortas.. J Vis Exp. (53)

Darnell JC, Van Driesche SJ, Zhang C, Hung KYing Sharo, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SWook et al..  2011.  FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.. Cell. 146(2):247-61.

Verma A, Verma N.  2011.  Induced pluripotent stem cells and promises of neuroregenerative medicine.. Neurol India. 59(4):555-7.

Webster YW, Dow ER, Koehler J, Gudivada RC, Palakal MJ.  2011.  Leveraging health social networking communities in translational research.. J Biomed Inform. 44(4):536-44.

Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, Decker B, Serpe JM, Dasu T, Tschannen MR, Veith RL et al..  2011.  Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.. Genet Med. 13(3):255-62.

Vemula PKumar, Boilard E, Syed A, Campbell NR, Muluneh M, Weitz DA, Lee DM, Karp JM.  2011.  On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease.. J Biomed Mater Res A. 97(2):103-10.

Lim JYul, Loiselle AE, Lee JSoon, Zhang Y, Salvi JD, Donahue HJ.  2011.  Optimizing the osteogenic potential of adult stem cells for skeletal regeneration.. J Orthop Res. 29(11):1627-33.

Jain A, Kovacs JA, Nelson DL, Migueles SA, Pittaluga S, Fanslow W, Fan X, Wong DW, Massey J, Hornung R et al..  2011.  Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.. Blood. 118(14):3811-7.

Tischfield MA, Cederquist GY, Gupta ML, Engle EC.  2011.  Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations.. Curr Opin Genet Dev. 21(3):286-94.

Zhang J, Kramer EG, Asp L, Dutta DJ, Navrazhina K, Pham T, Mariani JN, Argaw ATadesse, Melendez-Vasquez CV, John GR.  2011.  Promoting myelin repair and return of function in multiple sclerosis.. FEBS Lett. 585(23):3813-20.

Mayer AN, Dimmock DP, Arca MJ, Bick DP, Verbsky JW, Worthey EA, Jacob HJ, Margolis DA.  2011.  A timely arrival for genomic medicine.. Genet Med. 13(3):195-6.

Douglas FL, Narayanan VK, Mitchell L, Litan RE.  2010.  The case for entrepreneurship in R&D in the pharmaceutical industry.. Nat Rev Drug Discov. 9(9):683-9.

Lanier ST, Wang ED, Chen JJ, Arora BP, Katz SM, Gelfand MA, Khan SU, Dagum AB, Bui DT.  2010.  The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction.. Ann Plast Surg. 64(5):674-8.

Gaeta SA, Krogh-Madsen T, Christini DJ.  2010.  Feedback-control induced pattern formation in cardiac myocytes: a mathematical modeling study.. J Theor Biol. 266(3):408-18.

Chen Y-T, Nikulina K, Lazarev S, Bahrami AF, Noble LB, Gallup M, McNamara NA.  2010.  Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome.. Am J Pathol. 177(3):1333-43.

Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, Naves R, Han M, Zhong F, Castellanos JG et al..  2010.  T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.. Nat Med. 16(4):406-12.

Merrill DB, Girgis RR, Bickford LC, Vorel SR, Lieberman JA.  2010.  Teaching trainees to negotiate research collaborations with industry: a mentorship model.. Am J Psychiatry. 167(4):381-6.

Zhang Y, Zhang J, Navrazhina K, Argaw ATadesse, Zameer A, Gurfein BT, Brosnan CF, John GR.  2010.  TGFbeta1 induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation.. Glia. 58(8):964-74.